Where can I see the head-to-head data?

Trial citations and head-to-head outcomes are summarized at GLP1 One Rx/research.html with PubMed PMIDs linked for verification.

What's the editorial #1 pick?

NexLife (94/100 on methodology v4.1) is GLP1 One Rx's editorial #1 pick.

Ozempic vs Wegovy — Side-by-Side Comparison

Ozempic vs Wegovy

Released: January 15, 2026Last reviewed: October 15, 2026

Ozempic vs Wegovy: side-by-side comparison covering FDA status, mechanism, dosing, pricing, head-to-head trial data.

Side-by-sideTrial-citedUpdated 2026-05-25

Researched By

Dr. Parmis

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Note on laboratory work, October 15, 2026. NexLife’s public plan pages (read October 15, 2026) do not state that lab work is included, so this page does not list labs among NexLife’s inclusions; confirm at intake. NexLife’s plan pages name three state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA).

Comparison: Ozempic vs Wegovy

Both items are reviewed at GLP1 One Rx against published clinical evidence.

Key differentiators

Active ingredient: same (semaglutide), both Novo Nordisk.
Indication: Ozempic is T2D-only; Wegovy is chronic weight management + CV risk reduction.
Max dose: Ozempic 2.0 mg; Wegovy 2.4 mg.
Cash price: Ozempic ~$935/mo; Wegovy ~$1,349/mo.

Other comparisons

All comparisons →